These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7370051)

  • 1. Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic.
    Verbeeck RK; Boel A; Buntinx A; De Schepper PJ
    Biochem Pharmacol; 1980 Feb; 29(4):571-6. PubMed ID: 7370051
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of chronic renal failure and hemodialysis on diflunisal plasma protein binding.
    Verbeeck RK; De Schepper PJ
    Clin Pharmacol Ther; 1980 May; 27(5):628-35. PubMed ID: 7371361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between protein binding of bilirubin, salicylic acid, and sulfisoxazole in serum of unmedicated and phenobarbital-treated rats.
    Yacobi A; Oie S; Levy G
    J Pharm Sci; 1977 Jul; 66(7):1025-7. PubMed ID: 886438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting drug-protein binding in the plasma of newborn infants.
    Wallace S
    Br J Clin Pharmacol; 1976 Jun; 3(3):510-2. PubMed ID: 973977
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of heparin injection on plasma protein binding of bilirubin and salicylate in rats.
    Wiegand UW; Levy G
    J Pharm Sci; 1979 Dec; 68(12):1483-6. PubMed ID: 529035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased drug binding in serum from patients with chronic hepatic disease.
    Wallace S; Brodie MJ
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):429-32. PubMed ID: 971706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilirubin-albumin binding in neonatal salicylate intoxication.
    Ahlfors CE; Shwer ML; Ford KB
    Dev Pharmacol Ther; 1982; 4(1-2):47-60. PubMed ID: 7117090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diflunisal interference with determination of salicylate by the Trinder, Abbott TDx, and Du Pont aca methods.
    Dalrymple RW; Stearns FM
    Clin Chem; 1986 Jan; 32(1 Pt 1):230. PubMed ID: 3940724
    [No Abstract]   [Full Text] [Related]  

  • 9. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diflunisal cross-reactivity with the Trinder method for salicylate determination.
    Nordt SP
    Ann Pharmacother; 1996 Sep; 30(9):1041-2. PubMed ID: 8876878
    [No Abstract]   [Full Text] [Related]  

  • 11. Diflunisal significantly interferes with salicylate measurements by FPIA-TDx and UV-VIS aca methods.
    Sarma L; Wong SH; DellaFera S
    Clin Chem; 1985 Nov; 31(11):1922-3. PubMed ID: 3902292
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate, in vitro.
    Mason RW; McQueen EG
    Pharmacology; 1974; 12(1):12-9. PubMed ID: 4419599
    [No Abstract]   [Full Text] [Related]  

  • 13. A new approach to the determination of protein-bound bilirubin displacement and its applications.
    Coutinho CB; Lucek RW; Cheripko JA; Kuntzman R
    Ann N Y Acad Sci; 1973 Nov; 226():238-46. PubMed ID: 4520395
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs.
    Decroix MO; Zini R; Chaumeil JC; Tillement JP
    Biochem Pharmacol; 1988 Jul; 37(14):2807-14. PubMed ID: 3395358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of diflunisal acyl glucuronide in human and rat plasma and albumin solutions.
    Watt JA; Dickinson RG
    Biochem Pharmacol; 1990 Mar; 39(6):1067-75. PubMed ID: 2322294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between diflunisal and warfarin.
    Serlin MJ; Mossman S; Sibeon RG; Tempero KF; Breckenridge AM
    Clin Pharmacol Ther; 1980 Oct; 28(4):493-8. PubMed ID: 7408409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of the protein binding of drugs by continuous ultrafiltration. 9. Comparison of the binding of nonsteroid antirheumatics to human serum albumin and their interaction with phenprocoumon].
    Rehse K; Fiedler B
    Arch Pharm (Weinheim); 1989 Apr; 322(4):241-3. PubMed ID: 2751413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of salicylic acid on pharmacokinetics of free and plasma protein-bound bilirubin in experimental unconjugated hyperbilirubinemia.
    Oie S; Levy G
    J Pharm Sci; 1979 Jan; 68(1):1-6. PubMed ID: 758439
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.
    Loewen GR; Herman RJ; Ross SG; Verbeeck RK
    Br J Clin Pharmacol; 1988 Jul; 26(1):31-9. PubMed ID: 3203058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of diflunisal on the pharmacokinetics of oxazepam.
    van Hecken AM; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1985 Sep; 20(3):225-34. PubMed ID: 4041343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.